Status:
RECRUITING
Biliary Dilatation National Special Disease Cohort in China
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Conditions:
Choledochal Cyst
Eligibility:
All Genders
Up to 80 years
Brief Summary
This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data...
Detailed Description
Biliary Dilatation(BD) is a complex benign biliary disorder prevalent in East Asia, for which surgical resection remains the sole curative approach necessitating prompt intervention upon diagnosis. Ne...
Eligibility Criteria
Inclusion
- Patients who have been definitive diagnosed with biliary dilation.
- Patients aged between 0 and 80 years old, regardless of gender.
- In line with the principle of informed consent: For the retrospective cohort of biliary dilation, exemption from signing the informed consent form is applied for, while for the prospective cohort, signing the informed consent form is required.
Exclusion
- None
Key Trial Info
Start Date :
March 19 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2035
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT06881004
Start Date
March 19 2025
End Date
March 31 2035
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, China, 102218